RHB-106 is a proprietary oral bowel preparation capsule for GI tract procedures. RHB-106 was acquired from Sydney-based Giaconda [ASX: GIA] in August 2010. RHB-106, a tasteless formulated capsule containing electrolytes, targets the indication of oral bowel preparation for GI tract procedures. It potentially avoids patient exposure to the often unacceptable taste of current products and allows for an unobstructed procedure with reduced side effects and improved compliance. Phase IIa has been completed in Australia with significantly improved patient response and equal bowel cleansing and RedHill is currently executing its development plan.
Latest News
- May 2, 2013
RedHill Biopharma Reports Financial Results for the First Quarter of 2013 - March 27, 2013
RedHill Biopharma Submits NDA for U.S. Marketing of RHB-103 Anti-Migraine Oral Thin Film - March 19, 2013
RedHill Biopharma Provides Update on RHB-101 (Cardio) Scientific Advice Meeting and Planned Marketing Application Submission in Europe - March 6, 2013
RedHill Biopharma to Present at the 25th Annual ROTH Conference – March 19 2013 - February 25, 2013
RedHill Biopharma Provides Update on Development Progress and Planned NDA Submission for RHB-102 (oncology support, anti-emetic)
See More News